Validation of in-vitro data by in-vivo evidence: The example of angiotensin (1-7)

Journal of Hypertension

Volumn 24, Issue 10, 2006, Pages 1919-1920

  Brunner, Hans R ^a   Gavras, Haralambos ^b  

^a NONE   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN[1-7];

CARDIOVASCULAR FUNCTION; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY BLOOD FLOW; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VALIDATION PROCESS; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 33748542939     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000244936.26922.b0     Document Type: Note

References (5)

1. van den Wouden EA, Ochodnický P, van Dokkum RPE, Roks AJM, Deelman LE, de Zeeuw DH, Henning RH. The role of angiotensin-(1-7) in renal vasculature of the rat. J Hypertens 2006; 24:1971-1978.
2. Handa RK, Ferrario CM, Strandhoy JW. Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol 1996; 270:F141-F147.
3. Ren Y, Garvin JL, Carretero OA. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 2002; 39:799-802.
4. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol 1995; 269:H313-H319.
5. Widdop RE, Sampey DB, Jarrott B. Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats. Hypertension 1999; 34:964-968.